• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Cheers AltX, howzit main board for Enaleni

      Posted AtMoneyweb.co.za

      AltX-listed Enaleni has outgrown the junior bourse and is to list on the JSE tomorrow.

      This comes as the company's R1,2bn acquisition of Cipla Medpro, the SA subsidiary of Indian generic drug maker Cipla, was given the go-ahead by Enaleni shareholders at the company's general meeting yesterday.

      Part of the purchase of Medpro will be paid through the issue of 39,3m new Enaleni shares at 280c each worth R110m.

      The company successfully raised another R990m through a combination of debt and equity funding in mid-November.

      The JSE has approved the issue of an extra 284 465 768 shares to be listed today. Enaleni CEO Trevor Edwards was in a meeting when Moneyweb called, and was thus unable to answer questions.

      The JSE's rules require companies to have three years of profit history before they can qualify to list on the main board. According to the Enaleni website, the company was formed on January 2, 2003, making it less than three years' old.

      However, JSE listings head John Burke says that the combined profit history of Enaleni and Cipla Medpro make it eligible for listing on the main board.

      "Also," says Burke," a company can opt to stay on the AltX, but if it wants to move it has to comply with all the JSE's rules."

      These include a minimum pre-tax profit of R8m (for AltX, there is no minimum), a shareholder spread of 20% (AltX: 10%), and a minimum of 500 shareholders (AltX: 100).

      Moreover, JSE companies have to pay an annual listing fee of 0,04% of its market cap, with a minimum of R26 334 and maximum of R121 700. On the AltX, the amount is R20 000.

      AltX directors are also required to attend a directors' induction programme, whereas this is not necessary for JSE companies.

      Enaleni shares shed 8,1% by the close of business, ending the day at R3,31.

      December 14, 2005


      Share this Article!

    Back to top^